Takeda Pharmaceutical to buy U.S. cancer drug maker Ariad in $4.7 billion deal – The Japan Times


Business Insider
Takeda Pharmaceutical to buy U.S. cancer drug maker Ariad in $4.7 billion deal
The Japan Times
Japanese drugmaker Takeda Pharmaceutical will buy U.S. cancer drug developer Ariad Pharmaceuticals in a $4.66 billion deal that the companies expect to close by the end of February. Takeda will pay $24 in cash for each Ariad share, a premium of nearly¬†…
‘Staggering’ Price Hikes Resulted In $5 Billion Payday For Ariad Pharma InvestorsForbes
Takeda is buying Ariad Pharmaceuticals in a $5.2 billion dealBusiness Insider
Takeda Pharmaceutical to buy Ariad in $4.7 billion cash deal660 News
CNBC
all 94 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd